Pakistan Pharmaceutical Manufacturers’ Association (PPMA) leader Amjad Ali said on Saturday PPMA member firms were focussed on manufacturing good quality drugs. “We feel perturbed when substandard drugs are called spurious drugs,” Ali told the media at a local hotel.
He said that a spurious drug was the one that was a fake or produced by unlicensed manufacturers. He said the case of substandard drugs was different as the manufacturers did not usually do anything deliberately in this case. “If regulators detect a substandard drug, the manufacturers are fined.” He stressed the need for a regulator that proactively checked the quality of drugs and took action against any non-compliant manufacturers.
Published in The Express Tribune, August 16th, 2015.
COMMENTS
Comments are moderated and generally will be posted if they are on-topic and not abusive.
For more information, please see our Comments FAQ